Estudo revelou que o obexelimabe produziu melhora clnica rpida, forte e sustentada, incluindo remisso clnica completa, na maioria dos pacientes com IgG4–RD ativa
Os resultados apoiam o [...] Read more »
Zenas BioPharma gibt die Veröffentlichung von Daten zu einer Phase-2-Studie mit Obexelimab, einem Prüfpräparat zur Behandlung der IgG4-assoziierten Erkrankung (IgG4-RD), im Fachjournal „The Lancet Rheumatology“ bekannt
Die Studie ergab, dass Obexelimab bei den meisten Patientinnen und Patienten mit aktiver IgG4–RD zu einer schnellen, deutlichen und anhaltenden klinischen Verbesserung, einschlielich einer vollstndigen klinischen [...] Read more »
Zenas BioPharma annonce la publication d'une étude de phase 2 sur l'obéxélimab, un traitement expérimental pour la maladie liée aux IgG4 (ML-IgG4), dans The Lancet Rheumatology
L'tude a montr que l'obxlimab produisait une amlioration clinique rapide, forte et soutenue, y compris une rmission clinique complte, chez la plupart des patients atteints de ML–IgG4 active
Read more »
The Coretec Group Launches its Endurion Partner Development Program
ANN ARBOR, Mich., Aug. 02, 2023 (GLOBE NEWSWIRE) — Read more »
Climate Change Is Making Us Sick, Says WHO Envoy
Read more »
Education Cannot Wait Interviews The Rt. Hon. Andrew Mitchell, United Kingdom Minister of State (Development and Africa)
By External Source
Aug 2 2023 [...] Read more »
Women Shatter Gender Barriers in Uganda’s Fish Farming Industry
Women fishing in Lake [...] Read more »
Clock Is Ticking For Food Security In Africa, Says New IITA Head
![Radio IITA interviews [...] <a class=](https://www.ipsnews.net/Library/2023/08/Radio-IITA-interviews-Dr-Simeon-Ehui-Photo-by-IITA-300x200.jpeg)
Read more »
Government Health Financing for All, Not Insurance
By Jomo Kwame Sundaram and Nazihah Noor
KUALA LUMPUR and BERN, Aug 2 2023 - To achieve universal health coverage, people need public healthcare systems providing fair access to decent health care. This should be an entitlement for all, [...] Read more »